Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07521748) titled 'A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses in Healthy Adult Participants' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Nanjing Reju Therapeutics Co., Ltd
Condition:
Dry Eye
Intervention:
Drug: RC017 Ophthalmic Ointment
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 2026
Target Sample Size: 24
To know more, visit ...